文献速递慢性肾脏病肾血管病与高血压

谷胱甘肽过氧化物酶-3严重缺乏与慢性肾脏病临床前模型导致冠状动脉血栓形成和左心室功能抑制

Pre-clinical model of severe glutathione peroxidase-3 deficiency and chronic kidney disease results in coronary artery thrombosis and depressed left ventricular function.
PubMed 文献 · Nephrol Dial Transplant · 2018-01-01

该研究在GPx3基因敲除小鼠中构建手术诱导的慢性肾脏病模型,发现GPx3缺乏加重心脏功能障碍和血栓形成。GPx3-/-+CKD小鼠射血分数缩短至32.9±5.8%,而WT+CKD为62.0%±10.3%(P<0.001)。依布硒啉治疗可改善血小板聚集和左心室功能。

要点

  • GPx3缺乏加重CKD诱导的心脏功能障碍和心肌血小板聚集。
  • GPx3-/-+CKD小鼠左室缩短分数显著低于WT+CKD(P<0.001)。
  • 依布硒啉可减轻血小板聚集并改善左室功能。

核心结论

  • GPx3缺乏是肾脏疾病诱导的心脏病发展的实质性促进因素。

研究设计与样本

  • 研究使用GPx3基因敲除小鼠(GPx3-/-)在手术诱导的慢性肾脏病模型中进行。

主要发现

  • GPx3-/-+CKD小鼠射血分数缩短至32.9±5.8%,而WT+CKD为62.0%±10.3%(P<0.001)。
  • GPx3-/-+CKD小鼠心肌中血小板聚集增加。
  • GPx3-/-+CKD和WT+CKD中ADMA水平均升高。
  • ADMA刺激GPx3-/-洗涤血小板自发聚集更快。
  • GPx3-/-+CKD样本体外血小板聚集增强,体内给予依布硒啉后血小板聚集减轻,且FS改善。

关键数值与推荐

  • GPx3-/-+CKD小鼠FS为32.9±5.8%,WT+CKD为62.0%±10.3%(P<0.001)。

临床怎么用

  • GPx3缺乏可能作为CKD患者心血管疾病的风险因素,依布硒啉或为潜在治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic kidney disease (CKD) patients have deficient levels of glutathione peroxidase-3 (GPx3). We hypothesized that GPx3 deficiency may lead to cardiovascular disease in the presence of chronic kidney disease due to an accumulation of reactive oxygen species and decreased microvascular perfusion of the myocardium. Methods. To isolate the exclusive effect of GPx3 deficiency in kidney disease-induced cardiac disease, we studied the GPx3 knockout mouse strain (GPx3-/-) in the setting of surgery-induced CKD. Results. Ribonucleic acid (RNA) microarray screening of non-stimulated GPx3-/- heart tissue show increased expression of genes associated with cardiomyopathy including myh7, plac9, serpine1 and cd74 compared with wild-type (WT) controls. GPx3-/- mice underwent surgically induced renal mass reduction to generate a model of CKD. GPx3-/- + CKD mice underwent echocardiography 4 weeks after injury. Fractional shortening (FS) was decreased to 32.9 ± 5.8% in GPx3-/- + CKD compared to 62.0% ± 10.3 in WT + CKD (P < 0.001). Platelet aggregates were increased in the myocardium of GPx3-/- + CKD. Asymmetric dimethylarginine (ADMA) levels were increased in both GPx3-/- + CKD and WT+ CKD. ADMA stimulated spontaneous platelet aggregation more quickly in washed platelets from GPx3-/-. In vitro platelet aggregation was enhanced in samples from GPx3-/- + CKD. Platelet aggregation in GPx3-/- + CKD samples was mitigated after in vivo administration of ebselen, a glutathione peroxidase mimetic. FS improved in GPx3-/- + CKD mice after ebselen treatment. CONCLUSION: These results suggest GPx3 deficiency is a substantive contributing factor to the development of kidney disease-induced cardiac disease.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Pang P, Abbott M, Abdi M, et al. Pre-clinical model of severe glutathione peroxidase-3 deficiency and chronic kidney disease results in coronary artery thrombosis and depressed left ventricular function. Nephrol Dial Transplant. 2018. PMID: 29244159. doi:10.1093/ndt/gfx304

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。